Loading insider details...
Beta
Latest Form 4 (Jun 24, 2026): Exercise/Conversion of 25,000 AQST shares, $17.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Aquestive Therapeutics, Inc. (AQST) | Exercise/Conversion | 25,000 | $17.8K |
| Jun 12, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 50,500 | n/a |
| Jun 3, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 67,500 | n/a |
| Nov 3, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 450,000 | n/a |
| Jun 12, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 42,000 | $143.2K |
| Jun 21, 2024 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 38,000 | n/a |
| Jun 23, 2023 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |
| Jun 24, 2022 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |
| Jun 17, 2021 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 20,000 | n/a |
| Mar 15, 2021 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 28,500 | n/a |